Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

DataSheet_5_Exploring the causality and pathogenesis of systemic lupus erythematosus in breast cancer based on Mendelian randomization and transcriptome data analyses.docx by Wenjie Li (6558)

“…Furthermore, sensitivity analyses proved the robustness of the present MR results. A prognostic SLEscore consisting of five SLE-related genes (RACGAP1, HMMR, TTK, TOP2A, and KIF15) could distribute patients with breast cancer into the high- and low-risk groups according to survival rates with good predictive ability (p < 0.05).…”

Image_5_Smoothelin-like protein 1 promotes insulin sensitivity and modulates the contractile properties of endometrial epithelial cells with insulin resistance.tif by Ilka Keller (11522881)

Data Sheet 5_Global, regional, and national burden of tuberculosis due to smoking, 1990-2021: analysis for the Global Burden of Disease study.xlsx by Guizeng Zhao (21785336)

Table_5_Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota.XLS by Sijia Li (702720)

PIK3C3 promotes the resolution of VLPs into DMVs through formation of PtdIns(3)P at the protrusion/VLP membrane. by Steven J. Rolland (21376879)

Image_2_Tyrosine-Protein Phosphatase Non-receptor Type 9 (PTPN9) Negatively Regulates the Paracrine Vasoprotective Activity of Bone-Marrow Derived Pro-angiogenic Cells: Impact on V... by Michel Desjarlais (6832442)

“…Because Tyrosine-protein phosphatase non-receptor type 9 (PTPN9) is reported to be a negative regulator of stem cell differentiation and angiogenesis signaling, we investigated its effect on PAC activity in the context of OIR.…”

Table_1_Tyrosine-Protein Phosphatase Non-receptor Type 9 (PTPN9) Negatively Regulates the Paracrine Vasoprotective Activity of Bone-Marrow Derived Pro-angiogenic Cells: Impact on V... by Michel Desjarlais (6832442)

“…Because Tyrosine-protein phosphatase non-receptor type 9 (PTPN9) is reported to be a negative regulator of stem cell differentiation and angiogenesis signaling, we investigated its effect on PAC activity in the context of OIR.…”

Image_3_Tyrosine-Protein Phosphatase Non-receptor Type 9 (PTPN9) Negatively Regulates the Paracrine Vasoprotective Activity of Bone-Marrow Derived Pro-angiogenic Cells: Impact on V... by Michel Desjarlais (6832442)

“…Because Tyrosine-protein phosphatase non-receptor type 9 (PTPN9) is reported to be a negative regulator of stem cell differentiation and angiogenesis signaling, we investigated its effect on PAC activity in the context of OIR.…”

Image_1_Tyrosine-Protein Phosphatase Non-receptor Type 9 (PTPN9) Negatively Regulates the Paracrine Vasoprotective Activity of Bone-Marrow Derived Pro-angiogenic Cells: Impact on V... by Michel Desjarlais (6832442)

“…Because Tyrosine-protein phosphatase non-receptor type 9 (PTPN9) is reported to be a negative regulator of stem cell differentiation and angiogenesis signaling, we investigated its effect on PAC activity in the context of OIR.…”

Model for Nrd1-dependent and Nrd1-independent roles of Nab3 in facilitating TRAMP function in the recruitment of the exosome for RNA processing/degradation. by Milo B. Fasken (659389)

Video 3_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

“…</p>Animals<p>Fifty client-owned dogs with severe degenerative MR operated over a 28-month period.</p>Methods<p>TEER was performed using the canine mitral V-Clamp via a transapical approach using transesophageal echocardiographic and fluoroscopic guidance. …”

Video 6_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

“…</p>Animals<p>Fifty client-owned dogs with severe degenerative MR operated over a 28-month period.</p>Methods<p>TEER was performed using the canine mitral V-Clamp via a transapical approach using transesophageal echocardiographic and fluoroscopic guidance. …”

Video 1_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

“…</p>Animals<p>Fifty client-owned dogs with severe degenerative MR operated over a 28-month period.</p>Methods<p>TEER was performed using the canine mitral V-Clamp via a transapical approach using transesophageal echocardiographic and fluoroscopic guidance. …”

Data Sheet 1_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.pdf by Brianna M. Potter (20401199)

“…</p>Animals<p>Fifty client-owned dogs with severe degenerative MR operated over a 28-month period.</p>Methods<p>TEER was performed using the canine mitral V-Clamp via a transapical approach using transesophageal echocardiographic and fluoroscopic guidance. …”

Data Sheet 2_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.pdf by Brianna M. Potter (20401199)

“…</p>Animals<p>Fifty client-owned dogs with severe degenerative MR operated over a 28-month period.</p>Methods<p>TEER was performed using the canine mitral V-Clamp via a transapical approach using transesophageal echocardiographic and fluoroscopic guidance. …”

Data Sheet 3_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.pdf by Brianna M. Potter (20401199)

“…</p>Animals<p>Fifty client-owned dogs with severe degenerative MR operated over a 28-month period.</p>Methods<p>TEER was performed using the canine mitral V-Clamp via a transapical approach using transesophageal echocardiographic and fluoroscopic guidance. …”

Video 7_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

“…</p>Animals<p>Fifty client-owned dogs with severe degenerative MR operated over a 28-month period.</p>Methods<p>TEER was performed using the canine mitral V-Clamp via a transapical approach using transesophageal echocardiographic and fluoroscopic guidance. …”